PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians

NCT03859414 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Therapeutic Dose 1
DRUG: Therapeutic Dose 2
DRUG: Supra-therapeutic Dose
DRUG: Placebo

Sponsor

Chiesi Farmaceutici S.p.A.